Literature DB >> 18154539

Prevalence of extended-spectrum beta-lactamases in South America.

M V Villegas1, J N Kattan, M G Quinteros, J M Casellas.   

Abstract

In South American countries, the class A extended-spectrum beta-lactamases (ESBLs) so far recognised belong to the CTX-M, Pseudomonas Extended Resistance (PER), SHV and TEM families. ESBL rates in South America are among the highest in the world, probably due to multiple factors. SHV- and TEM-type ESBLs have been frequently encountered, but CTX-M is endemic and widely dominant. PER-type ESBLs seem to be restricted to the southern 'cone' of South America. Community-acquired ESBLs are starting to appear.

Mesh：

Substances：

Year:  2008        PMID： 18154539     DOI： 10.1111/j.1469-0691.2007.01869.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  28 in total

1.  Characterization of fecal extended-spectrum-β-lactamase-producing Escherichia coli in a remote community during a long time period.

Authors:  Paul-Louis Woerther; Cécile Angebault; Hervé Jacquier; Olivier Clermont; Assyia El Mniai; Brigitte Moreau; Félix Djossou; Gilles Peroz; François Catzeflis; Erick Denamur; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

2.  Characterization of IncI1 sequence type 71 epidemic plasmid lineage responsible for the recent dissemination of CTX-M-65 extended-spectrum β-lactamase in the Bolivian Chaco region.

Authors:  Eleonora Riccobono; Vincenzo Di Pilato; Tiziana Di Maggio; Carmen Revollo; Alessandro Bartoloni; Lucia Pallecchi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

3.  Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.

Authors:  Thomas Tängdén; Otto Cars; Asa Melhus; Elisabeth Löwdin
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Prevalence of the bla (SHV) gene in Klebsiella pneumoniae isolates obtained from hospital and community infections and from the microbiota of healthy individuals in Recife, Brazil.

Authors:  Dyana Leal Veras; Luiz Carlos Alves; Fábio André Brayner; Duschinka Ribeiro Duarte Guedes; Maria Amélia Vieira Maciel; Cíntia Renata Costa Rocha; Ana Catarina de Souza Lopes
Journal:  Curr Microbiol       Date:  2011-02-27       Impact factor: 2.188

Review 5.  Early-onset neonatal sepsis.

Authors:  Kari A Simonsen; Ann L Anderson-Berry; Shirley F Delair; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

6.  Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.

Authors:  Christopher R Bethel; Magdalena Taracila; Teresa Shyr; Jodi M Thomson; Anne M Distler; Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Krisztina Papp-Wallace; Richard Bonnet; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

7.  First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America.

Authors:  Sory J Ruiz; Maria Camila Montealegre; Patricia Ruiz-Garbajosa; Adriana Correa; David F Briceño; Ernesto Martinez; Fernando Rosso; Martin Muñoz; John P Quinn; Rafael Cantón; Maria Virginia Villegas
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

Review 8.  Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices.

Authors:  Johann D D Pitout
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

9.  Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  Johann Dd Pitout
Journal:  F1000 Med Rep       Date:  2009-11-16

10.  International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum beta-lactamases in a Czech hospital.

Authors:  Jaroslav Hrabák; Joanna Empel; Tamara Bergerová; Karel Fajfrlík; Pavla Urbásková; Izabela Kern-Zdanowicz; Waleria Hryniewicz; Marek Gniadkowski
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.